June 30, 2020 | Article

Vega expert Dr. Daniel Taylor recently published a report regarding corporate disclosure choices during the COVID-19 pandemic. Dr. Taylor and his co-authors discuss how the COVID-19 pandemic presents a scenario where the unexpected shock to the economic system led to a rapid deterioration in the economic landscape, causing sharp change in performance relative to expectation. An examination of the corporate disclosures among over three thousand publicly listed SEC filings for references to COVID-19 showed that decisions varied considerably about whether to make disclosures about the pandemic’s impact on operations and finances.

Dr. Taylor is an expert in financial disclosures, accounting fraud, insider trading, corporate governance, and executive compensation. He has provided consulting and expert services related to best practices in business decision making and undisclosed regulatory investigations.

The views expressed in this article are solely those of the authors, who are responsible for the content, and do not necessarily represent the views of Vega Economics. To retain Dr. Taylor as an expert, please email experts@vegaeconomics.com.

 The Spread of COVID-19 Disclosure